Trials / Terminated
TerminatedNCT00302770
Efficacy of Quetiapine in Generalised Social Anxiety Disorder
Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2006-03-15
- Last updated
- 2011-01-27
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00302770. Inclusion in this directory is not an endorsement.